在ADHD的iPSC模型中,omega-3脂肪酸及其与甲基酸的组合对神经发育的影响
Natalie M Walter1, Cristine M Yde Ohki2, Sina Ruhstaller2
1Department of Child and Adolescent Psychiatry and Psychotherapy, Translational Molecular Psychiatry, Psychiatric University Hospital Zurich, University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland; ZNZ PhD Program, University of Zurich, Winterthurerstrasse 11, 8057, Zurich, Switzerland.
Journal of psychiatric research
|March 5, 2025
概括
欧米茄3/6多不和脂肪酸 (PUFA) 在调节注意力缺陷/多动性障碍 (ADHD) 神经发育的Wnt信号传递方面具有潜力. 个性化的PUFA治疗可能会使ADHD患者受益,特别是那些对传统疗法没有反应的患者.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 与神经发育的改变有关.
- Wnt信号对大脑发育至关重要,可能在ADHD中发挥作用.
- 目前的ADHD疗法对一些患者的疗效有限,需要新的方法.
研究的目的:
- 研究Wnt信号在ADHD中的作用.
- 确定 ω-3/6 多不和脂肪酸 (PUFA) 是否可以调节ADHD中的Wnt信号.
- 评估PUFA和甲基酸盐 (MPH) 对ADHD神经发育机制的联合作用.
主要方法:
- 利用来自ADHD患者和对照者的诱导多能干细胞 (iPSC) 衍生的神经干细胞 (NSC).
- 研究了 ω-3/6 PUFA 治疗单独或与 MPH 治疗对 Wnt 信号通路的影响.
- 在不同ADHD患者小组中比较治疗效果.
主要成果:
- ω-3/6 PUFA 证明了在NSC中对Wnt活动的差异调节.
- 治疗效果因患者的病情和PUFA成分而异.
- 在ADHD患者衍生的NSC中观察到不同的神经发育反应.
结论:
- ω-3/6PUFAs在ADHD中显示出个性化的神经发育支持的前景.
- 调查ADHD子组,特别是那些对兴奋剂不反应的子组,对于理解不同的表型至关重要.
- 用PUFA准Wnt信号可能为特定的ADHD人群提供一种新的治疗策略.
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K